Trial no.:
|
PACTR202205899389032 |
Date of Approval:
|
13/05/2022 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Effect of a hemoglobinopathy nursing program on pediatric student nurses’ awareness and performance |
Official scientific title |
Effect of A Hemoglobinopathy Nursing Program on Pediatric Nursing Students' Performance: A Randomized Control Trial |
Brief summary describing the background
and objectives of the trial
|
Hemoglobinopathies are the most common life threatening, monogenic disorders in the world. The most common causes of hemoglobinopathies are sickle cell disease and thalassemia. Aim: This study aimed to evaluate the effect of a hemoglobinopathy nursing program on pediatric nursing students' performance. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Haematological Disorders |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Education /Training |
Anticipated trial start date |
04/02/2017 |
Actual trial start date |
11/02/2017 |
Anticipated date of last follow up |
30/03/2017 |
Actual Last follow-up date |
27/04/2017 |
Anticipated target sample size (number of participants) |
108 |
Actual target sample size (number of participants) |
108 |
Recruitment status |
Completed |
Publication URL |
http://srv2.eulc.edu.eg/eulc_v5/Libraries/Thesis/BrowseThesisPages.aspx?fn=PublicDrawThesis&BibID=12584471 |
|